Human papillomavirus infection requires cell surface heparan sulfate

J Virol. 2001 Feb;75(3):1565-70. doi: 10.1128/JVI.75.3.1565-1570.2001.

Abstract

Using pseudoinfection of cell lines, we demonstrate that cell surface heparan sulfate is required for infection by human papillomavirus type 16 (HPV-16) and HPV-33 pseudovirions. Pseudoinfection was inhibited by heparin but not dermatan or chondroitin sulfate, reduced by reducing the level of surface sulfation, and abolished by heparinase treatment. Carboxy-terminally deleted HPV-33 virus-like particles still bound efficiently to heparin. The kinetics of postattachment neutralization by antiserum or heparin indicated that pseudovirions were shifted on the cell surface from a heparin-sensitive into a heparin-resistant mode of binding, possibly involving a secondary receptor. Alpha-6 integrin is not a receptor for HPV-33 pseudoinfection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / physiology
  • COS Cells
  • Heparin / pharmacology
  • Heparitin Sulfate / physiology*
  • Humans
  • Integrin alpha6
  • Leukocyte L1 Antigen Complex
  • Membrane Glycoproteins / chemistry
  • Membrane Glycoproteins / physiology
  • Neural Cell Adhesion Molecules / chemistry
  • Neural Cell Adhesion Molecules / physiology
  • Papillomaviridae / physiology*
  • Virion / physiology*

Substances

  • Antigens, CD
  • Integrin alpha6
  • Leukocyte L1 Antigen Complex
  • Membrane Glycoproteins
  • Neural Cell Adhesion Molecules
  • Heparin
  • Heparitin Sulfate